ScripEvaxion Biotech A/S , which is using its artificial intelligence-based technology platform to develop immunotherapies, has unveiled positive data on two of its vaccine candidates that the Danish firm
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Pacts With Exscientia, BenevolentAI Wil
ScripThe World Trade Organization’s decision on a waiver of intellectual property rights for COVID-19 vaccines may have fallen short of expectations of some stakeholders in terms of addressing wider inequi